The paradox of T cell–mediated antitumor immunity in spite of poor clinical outcome in human melanoma

Author： Anichini Andrea Vegetti Claudia Mortarini Roberta

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.53, Iss.10, 2004-10, pp. : 855-864

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Suppression of Cell-mediated Immunity by Misonidazole

By Rockwell Sara Neaderland Marjorie Hope

International Journal of Radiation Biology, Vol. 42, Iss. 2, 1982-08 ,pp. : 185-189

Informa Healthcare

Access to resources Recommend Favorite

Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer

By Williams Benjamin Wall Meg Miao Rebecca Williams Brenda Bertoncello Ivan Kershaw Michael Mantamadiotis Theo Haber Michelle Norris Murray Gautam Anand Darcy Phillip Ramsay Robert

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 11, 2008-11 ,pp. : 1635-1645

Springer Publishing Company

Access to resources Recommend Favorite

IL-12 as an adjuvant for cell-mediated immunity

By Scott P. Trinchieri G.

Seminars in Immunology, Vol. 9, Iss. 5, 1997-10 ,pp. : 285-291

Academic Press

Access to resources Recommend Favorite

Natural killer cell-mediated recognition of human trophoblast

By Biassoni R. Bottino C. Millo R. Moretta L. Moretta A.

Seminars in Cancer Biology, Vol. 9, Iss. 1, 1999-02 ,pp. : 13-18

Academic Press

Access to resources Recommend Favorite

Chitooligosaccharides and N-acetyl-D-glucosamine stimulate peripheral blood mononuclear cell-mediated antitumor immune responses

Molecular Medicine Reports, Vol. 6, Iss. 2, 2012-01 ,pp. : 385-390

Spandidos Publications

Access to resources Recommend Favorite